GLP-1 Market Key Players AstraZeneca Boehringer Ingelheim D&D Pharmatech Eli Lilly Hanmi Pharmaceutical Novo Nordisk Pfizer Roche Sanofi Tonghua Dongbao Pharmaceutical GLP-1 Pipeline Phases The GLP-1 agonists industry is evolving with key players advancing candidates through clinical stages for obesity, diabetes, and cardiometabolic indications
For example, PAE not only protects against AS but also exerts neuroprotective effects by inhibiting neuronal ferroptosis in cerebral hemorrhage (Jin et al., 2021) and serves as an antidepressant (Wei et al., 2023)
Adults looking for skin radiance, healthy ageing, detox, and stress resilience
A time-tested growth-hormone-releasing peptide that encourages your bodys own natural production the foundational choice for recovery, lean muscle, and better sleep
These factors make it a strong, safe, and affordable candidate for STI prophylaxis (Luetkemeye, et al., 2023)
Regenerative clinic marketing peptide and hormone therapies